Research leaders to show total diet replacement’s role in tackling obesity and improving type 2 diabetes and osteoarthritis

Posted On: 17th May 2024

On 22nd May 2024, from 11:00 to 12:00 BST, Professor Henning Bliddal (Parker Institute, Frederiksburg Hospital) and Professor Mike Lean (University of Glasgow) will be joining a webinar hosted by TDMR Europe to demonstrate the effectiveness of total diet replacement (TDR) in tackling obesity and improving comorbidities.

Prof Lean will present the results of the DiRECT trial, the groundbreaking 5-year research which showed that type 2 diabetes (T2DM) remission in people with obesity is possible with a TDR diet, whereas Prof Bliddal will provide an insightful presentation on “Weight loss and medical management of osteoarthritis” discussing the feasibility of delivery of a ‘package of care’ including TDR for osteoarthritis.

As the levels of obesity and related diseases, such as T2DM, continue to increase at an alarming rate in Europe, this webinar aims to help public health professionals and policy makers gain a better understanding of TDR’s role in addressing these critical challenges that threaten to overwhelm the capacity of public health sector.

Entitled “Diabetes remission after weight loss with Total Diet Replacement (TDR): 5-year evidence and feasibility of use in osteoarthritis” the online seminar will be moderated by TDMR Europe’s Chair, Prof Anthony R. Leeds, who will also provide a brief description of the role of the organisation in ensuring that TDR composition legislation is science based.

The full agenda and free registration are available here.

For more information, please get in touch with the Press and Media Relations office of TDMR Europe at